Sexual health / libido (melanocortin)

PT-141

Bremelanotide, Vyleesi

FDA-approved

Based on expert consensus from publicly available videos plus public FDA/regulatory status — not medical advice. Peptides are prescription territory; consult a physician before using anything here.

The Verdict

One of the best-evidenced peptides people rarely talk about — FDA-approved for low sexual desire (Attia covers it clinically). A prescription drug, not a gray-market gamble.

The Evidence

FDA / Legal Status

FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women

Human Evidence

Human trials behind its FDA approval; on-demand subcutaneous injection ~45 min before activity

Sport / Doping

Prescription drug

Safety Flags

Transient nausea is common (~45%)
Limit frequency (~monthly) due to focal skin hyperpigmentation risk

Who Covers It

Peter Attia

Andrew Huberman

Other experts in the panel had no substantive coverage of this peptide — we don't guess their position.

Want the deep dive on PT-141?

This grade is free. Pro unlocks chat with the full expert dataset — ask about dosing, stacks, sourcing, and the exact citations behind every claim.

Cancel anytime

Go Deeper

Peptides: Full Report Common Question All Peptides

All peptides